Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | — | — |
he is having soreness around injection site; This spontaneous report was received from a consumer regarding himself, a male patient of unknown age. The patient's medical history, historical drugs, known drug allergies, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with with Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) as prophylaxis (volume of injection, route of administration, anatomical location, lot # and, expiration date were not reported). On an unknown date, the patient experienced soreness around injection site (Vaccination site pain). At the reporting time, the outcome of this event was unknown. The causal relationship between the event and the suspect vaccine was not provided. Additional information was not expected.